| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/24/1992 | US5098924 Hypotensive agents and angiotensin II inhibitors |
| 03/24/1992 | US5098923 Aromatase inhibiting 4(5)-imidazoles |
| 03/24/1992 | US5098911 Hemihydrate of 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride |
| 03/24/1992 | US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 03/24/1992 | US5098909 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction |
| 03/24/1992 | US5098908 Drugs for treatment of acne, seborrhea, female hirsurism and benign prostatic hypertropy |
| 03/24/1992 | US5098889 Cognition activators, angiotensin converting enzyme inhibitors |
| 03/24/1992 | US5098692 Gadolium complexes with N6-carboxymethyl-N3,N9-bis(methyl carbamoyl-methyl)-3,6,9-triazaundecanedioic acid and complexes with calcium |
| 03/24/1992 | US5098535 Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
| 03/24/1992 | CA1298034C Amino acid derivatives |
| 03/24/1992 | CA1297875C2 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h -receptor antagonists activity |
| 03/22/1992 | WO1992005162A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 03/22/1992 | WO1992005151A1 Crystallization of optical isomers of leukotriene antagonists |
| 03/22/1992 | WO1992004912A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 03/22/1992 | CA2091897A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 03/22/1992 | CA2091245A1 Crystallization of optical isomers of leukotriene antagonists |
| 03/22/1992 | CA2051803A1 Aromatase inhibiting 4(5)-imidazoles |
| 03/22/1992 | CA2051796A1 Vascular endothelial cell growth factor ii |
| 03/21/1992 | WO1992005186A1 Modified internucleoside linkages |
| 03/21/1992 | CA2092002A1 Modified internucleoside linkages |
| 03/20/1992 | WO1992005164A1 Novel aminobenzosultam derivatives as lipoxygenase inhibitors |
| 03/20/1992 | CA2089740A1 Aminobenzosultam derivatives as lipoxygenase inhibitors |
| 03/20/1992 | CA2050054A1 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/19/1992 | WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
| 03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| 03/19/1992 | WO1992004345A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 03/19/1992 | WO1992004334A1 Compounds |
| 03/19/1992 | WO1992004330A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004316A1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
| 03/19/1992 | WO1992004008A1 Composition for treating ocular pain |
| 03/19/1992 | WO1992003925A1 Treatment process for promoting weight loss employing a substituted δ5-androstene |
| 03/19/1992 | WO1992000287A3 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
| 03/19/1992 | WO1991019692A3 Calcium citrate malate composition |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/19/1992 | DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them |
| 03/19/1992 | DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14 |
| 03/19/1992 | CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds |
| 03/19/1992 | CA2090759A1 Treatment process for promoting weight loss employing a substituted 5-androstene |
| 03/19/1992 | CA2073003A1 Composition for treating ocular pain |
| 03/19/1992 | CA2051479A1 Heteroarylmethylbenzenes |
| 03/18/1992 | WO1992005163A1 5-trifluoroacylamino-2-aryl oxazoles |
| 03/18/1992 | WO1992005153A1 Antiproliferative substituted naphthalene compounds |
| 03/18/1992 | EP0475844A1 Use of N-(1.hexahydroazepinylalkyl) acetamides for the manufacture of medicaments for the treatment of disorders of the cholineogic transmission |
| 03/18/1992 | EP0475719A2 Platelet derived growth regulating peptide |
| 03/18/1992 | EP0475657A2 Pentapeptide and salts thereof having specific inhibiting effect of epidermal cell proliferation |
| 03/18/1992 | EP0475374A2 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
| 03/18/1992 | EP0475206A2 Angiotensin II receptor antagonists |
| 03/18/1992 | EP0475178A1 Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
| 03/18/1992 | EP0474733A1 Antihyperlipidemic and antiatherosclerotic urea compounds. |
| 03/18/1992 | EP0188573B1 Dietary supplement for minimizing effects of infection |
| 03/18/1992 | CN1059517A Acetamide derivatives |
| 03/18/1992 | CN1059457A Prodn of nutriment from "xianggu mushroom |
| 03/18/1992 | CA2091688A1 Antiproliferative substituted naphthalene compounds |
| 03/18/1992 | CA2090857A1 5-trifluoroacylamino-2-aryloxazoles 2-aryl-5-trifluoroacylaminooxazoles |
| 03/18/1992 | CA2050823A1 Fungicidal compositions and method |
| 03/18/1992 | CA2050043A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/18/1992 | CA2050042A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/18/1992 | CA2049506A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/17/1992 | US5096921 Organic compounds |
| 03/17/1992 | US5096918 Aldose reductase inhibitors, diabetes, galactosemia |
| 03/17/1992 | US5096911 Alteration of rate and character of hair growth |
| 03/17/1992 | US5096908 Method of inhibiting gastric acid secretion |
| 03/17/1992 | US5096901 Pharmacologically active amides and esters containing an azabicycloalkane moiety |
| 03/17/1992 | US5096717 Double-coated granules of disodium pamidronate |
| 03/17/1992 | CA1297632C Organic compounds and their pharmaceutical use |
| 03/17/1992 | CA1297631C Ureido renin inhibitors |
| 03/17/1992 | CA1297437C Process for the preparation of protease inhibitors |
| 03/17/1992 | CA1297410C Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| 03/15/1992 | WO1992004908A1 Drug containing cd14 |
| 03/15/1992 | CA2072626A1 Drug containing cd14 |
| 03/15/1992 | CA2050634A1 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
| 03/15/1992 | CA2025398A1 Diagnosis and treatment of a disorder of the gastrointestinal tract |
| 03/14/1992 | WO1992005178A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/14/1992 | WO1992005156A1 Pyridylthio or pyridyloxy alkanoic acids |
| 03/14/1992 | CA2092697A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/14/1992 | CA2091246A1 Indole ureas as 5 ht receptor antagonist |
| 03/14/1992 | CA2089728A1 Pyridylthio or pyridyloxy alkanoic acids |
| 03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
| 03/13/1992 | WO1992004369A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2091459A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2051091A1 Utilization of n-(1-hexahydroazepinylalkyl)acetamides for preparing drugs used for treating cholinergic transmission troubles |
| 03/12/1992 | DE4028398A1 Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung Phenylethanolamine, pharmaceutical compositions containing them and methods for their manufacture |
| 03/12/1992 | CA2051044A1 Cytostatic agent |
| 03/11/1992 | EP0474597A2 Diphenyl compounds as inhibitors of the arachidonic acid pathway and their use in pharmaceutical compositions |
| 03/11/1992 | EP0474561A1 Arylalkylamines, process for their preparation and pharmaceutical compositions containing them |
| 03/11/1992 | EP0474553A1 Actinonin derivatives |
| 03/11/1992 | EP0474374A1 Method for treatment of bone wasting diseases using a progestin |
| 03/11/1992 | EP0474291A1 HMG-COA reductase inhibitor metabolites |
| 03/11/1992 | EP0473936A1 Renin Inhibitors |
| 03/11/1992 | EP0473673A1 Method for protection from azt side effects and toxicity |
| 03/11/1992 | EP0473576A1 SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE |
| 03/11/1992 | EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
| 03/11/1992 | CA2050723A1 Angiotensin ii receptor antagonists |
| 03/10/1992 | US5095137 Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity |
| 03/10/1992 | US5095031 Indole derivatives which inhibit leukotriene biosynthesis |
| 03/10/1992 | US5095026 Prodrugs of carbonic anhydrase inhibitors |
| 03/10/1992 | US5095020 Cytostatic beta-carbolines |
| 03/10/1992 | US5095015 G-aminobutyric acid, anticonvulsants, tranquilizers, sleep disorders |